PharmaShots | Incisive News in 3 Shots

Subscribe Now

Aclaris

Aclaris Reports P-I (ATI-2138-PKPD-102) Trial Results of ATI-2138 for the Treatment of Immuno-Inflammatory Diseases

Aclaris Reports P-I (ATI-2138-PKPD-102) Trial Results of ATI-2138 for the Treatment of Immuno-Inflammatory Diseases

September 18, 2023

Aclaris Enters into a License Agreement with Pediatrix for Developing and Commercializing ATI-1777 in Greater China

Aclaris Enters into a License Agreement with Pediatrix for Developing and Commercializing ATI-1777 in Greater China

November 30, 2022

Insights+: COVID-19 Healthcare News Monthly Updates - June 2020

Insights+: COVID-19 Healthcare News Monthly Updates - June 2020

June 30, 2020

PharmaShots Weekly Snapshot (October 07-11, 2019)

PharmaShots Weekly Snapshot (October 07-11, 2019)

October 14, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us